GGOIX | VMGIX | GGOIX / VMGIX | |
Total Expense Ratio | 0.86 | 0.19 | 453% |
Annual Report Gross Expense Ratio | 1.01 | 0.19 | 532% |
Fund Existence | 26 years | 19 years | - |
Gain YTD | -6.638 | -2.943 | 226% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 878M | 27.2B | 3% |
Annual Yield % from dividends | 0.00 | 0.59 | - |
Returns for 1 year | 2.01 | 9.57 | 21% |
Returns for 3 years | 11.40 | 23.42 | 49% |
Returns for 5 years | 10.72 | 73.15 | 15% |
Returns for 10 years | -31.29 | 130.29 | -24% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TY | 29.47 | 0.22 | +0.75% |
TRI-Continental Corp | |||
EMHY | 38.15 | 0.21 | +0.55% |
iShares J.P. Morgan EM High Yld Bd ETF | |||
EMTY | 13.87 | 0.04 | +0.32% |
ProShares Decline of the Retl Store ETF | |||
FIAX | 17.98 | 0.04 | +0.25% |
Nicholas Fixed Income Alternative ETF | |||
BIB | 44.61 | -1.39 | -3.02% |
ProShares Ultra Nasdaq Biotechnology |